Body
More than one in ten cancer patients do not die from their cancer but from heart and blood vessel problems instead, according to new research published in the European Heart Journal [1] today (Monday). For some cancers, like breast, prostate, endometrial, and thyroid cancer, around half will die from cardiovascular disease (CVD).
Research Highlights:
One in 8 adults with common heart diseases skip medications, delay filling prescriptions or take less medication than prescribed because of concerns about cost.
Not taking medications as prescribed because of cost is 3 times more common in people under 65 years of age than in older people covered by Medicare.
SEATTLE, November 23, 2019 - Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.
Tsukuba, Japan - Insomnia is one of the most common sleep disorders, and is most commonly treated with hypnotics. However, hypnotics have motor and cognitive side effects. According to new findings from the University of Tsukuba in Japan, suvorexant, which is a recently approved and more targeted treatment, has fewer physical side effects.
A bacterial infection is not just an unpleasant experience - it can also be a major health problem. Some bacteria develop resistance to otherwise effective treatment with antibiotics. Therefore, researchers are trying to develop new types of antibiotics that can fight the bacteria, and at the same time trying to make the current treatment with antibiotics more effective.
Researchers have created a virtual reality clinic to make it easier for stroke survivors to attend their physical and occupational therapy sessions. Results from a proof-of-concept study suggest that the technology - and the social connection it facilitates - are effective at encouraging therapy participation.
Boston, MA - Among young women without an eating disorder diagnosis, those who use diet pills and laxatives for weight control had higher odds of receiving a subsequent first eating disorder diagnosis within one to three years than those who did not report using these products, according to a new study led by researchers from Harvard T.H. Chan School of Public Health and Boston Children's Hospital.
The GeMO - Genomics of a Mock Outbreak - was a stress test to the ability to identify and characterize multidrug-resistant bacteria isolated from patients and the hospital environment. The results, released on the European Antibiotic Awareness Day, 18 November, show that it is possible to sequence and analyze bacterial genomes in a short time, a crucial information to manage and control an outbreak.
Imagine not being able to drive, shower alone or even work because you are never quite sure when the next seizure will leave you incapacitated. Hope may be on the horizon for epilepsy patients who have had limited success with seizure drugs. In a study, led by a Johns Hopkins lead investigator, of 437 patients across 107 institutions in 16 countries, researchers found that the investigational drug cenobamate reduced seizures 55% on the two highest doses of this medication that were tested over the entire treatment period.
In a paper to be published in the forthcoming issue in NANO, researchers from Harbin Institute of Technology, China have systematically discussed the recent progresses, current challenges and future perspectives of smart graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging.
CDC guidelines say most children reach a milestone by a certain age, but new data shows that "most" may mean over 99% or barely half.
A new Boston University School of Public Health (BUSPH) study published in the journal Pediatrics provides more specific data on what ages young children reach different developmental milestones. Guidelines from the CDC say "most children" reach each milestone by a certain age, but do not define "most" and do not say how often or well a child should be demonstrating an ability.
Inducing labor after 41 instead of 42 full weeks' pregnancy appears to be safer in terms of perinatal survival, new Swedish research shows. The current study is expected to provide a key piece of evidence for upcoming decisions in maternity care.
In Sweden, the risk of a baby dying before, during or shortly after birth ("perinatal death") is generally very low. However, a progressive rise in risk from a low level is known to take place after the 40th week, for as long as the pregnancy continues.
New Rochelle, NY, November 21, 2019-Researchers are pursuing engineered bacteriophage as alternatives to antibiotics to infect and kill multi-drug resistant bacteria. The potential for an innovative synthetic biology approach to enhance phage therapeutics and the role a biofoundry can play in making this approach feasible and effective is discussed in an article in PHAGE: Therapy, Applications, and Research, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers launching in early 2020.
Pain is a mosaic. From a distance, it looks like one big "ouch." But if you step closer, many types of pain--like tiles of different shades--emerge. A headache doesn't feel like a papercut. The sting of denim against a sunburn is nothing like the jolt of ice against a sensitive tooth.
ANN ARBOR--With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs--including unlikely candidates--can be combined in new ways to create more effective treatments.
"This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive," said Sriram Chandrasekaran, U-M assistant professor of biomedical engineering, who leads the research.